Why AI matters at this scale

The University of Utah Department of Internal Medicine is a large academic clinical and research department within a major health system. It provides specialized patient care across numerous subspecialties (e.g., cardiology, gastroenterology), trains future physicians, and conducts groundbreaking medical research. At its size of 501-1000 employees, the department manages high patient volumes, complex cases, and vast amounts of structured and unstructured clinical data. This scale creates both a pressing need and a unique opportunity for AI. Manual processes strain resources, diagnostic complexity demands support, and research ambitions require faster insights. AI is not just an efficiency tool; it's a strategic lever to enhance clinical decision-making, accelerate discovery, and maintain competitive excellence in academic medicine.

Concrete AI Opportunities with ROI Framing

1. AI-Powered Clinical Documentation: Physician burnout is often fueled by administrative burdens. Implementing an ambient AI scribe to auto-generate visit notes from doctor-patient conversations can save 2-3 hours per clinician daily. For a department of this size, the ROI includes regained clinical time worth millions annually, improved job satisfaction, and more accurate, complete medical records that enhance billing and care quality.

2. Predictive Analytics for Patient Management: Internal medicine deals with chronic, often high-risk conditions. Machine learning models can analyze historical EHR data to predict patient deterioration or 30-day readmission risks with high accuracy. Proactive intervention for these flagged patients can significantly reduce costly hospital readmissions (a major cost center), improve patient outcomes, and optimize the use of case management resources. The ROI manifests in lower penalty costs from payers and better value-based care performance.

3. Intelligent Clinical Trial Matching: As an academic hub, recruiting patients for research is slow and manual. An AI system that continuously screens patient records against active trial eligibility criteria can dramatically accelerate enrollment. This increases research throughput, secures more grant funding, and brings new therapies to market faster. The ROI includes enhanced research prestige, additional revenue from clinical trials, and a stronger pipeline for translational medicine.

Deployment Risks Specific to a 501-1000 Employee Organization

Deploying AI at this mid-to-large scale in healthcare involves distinct risks. Integration Complexity is paramount; stitching AI tools into entrenched legacy systems like Epic requires significant IT effort and can disrupt clinical workflows if not managed carefully. Data Silos between clinical, research, and administrative units can hinder the creation of unified datasets needed for robust AI models. Change Management across a large, diverse group of physicians, researchers, and staff requires extensive training and clear communication of benefits to overcome skepticism. Budget Constraints are real; while not a small clinic, competing priorities for funding (clinical needs, faculty salaries, facilities) mean AI projects must demonstrate very clear and quick ROI to secure initial investment. Finally, Regulatory and Ethical Scrutiny is intense, requiring rigorous validation, transparency, and governance to ensure patient safety and maintain trust in an academic institution's recommendations.